. 1992. J. Biol. Chem. 267:21720-21726). Treatment of rats on a high salt diet with the epoxygenase inhibitor, clotrimazole, produces significant increases in mean arterial blood pressure (122 +/-2 and 145 +/-4 mmHg for salt and salt-and clotrimazole-treated rats, respectively). The salt-and clotrimazole-dependent hypertension is accompanied by reductions in the urinary excretion of epoxygenase metabolites and by a selective inhibition of the renal microsomal epoxygenase reaction. The prohypertensive effects of clotrimazole are readily reversed when either the salt or clotrimazole treatment is discontinued. The indication that a salt-inducible renal epoxygenase protects against hypertension, are supported by studies with the Dahl rat model of genetic salt-sensitive hypertension. Dahl resistant animals responded to excess dietary salt by inducing the activity of their kidney microsomal epoxygenase(s) (0.102 +/-0.01 and 0.240 +/-0.04 nmol of products formed/min per mg of microsomal protein for control and salt-treated rats, respectively). Despite severe hypertension during excess dietary salt intake (200 +/-20 mmHg), Dahl salt-sensitive rats demonstrated no increase in renal epoxygenase activity. Biol. Chem. 267:21720-21726). Treatment of rats on a high salt diet with the epoxygenase inhibitor, clotrimazole, produces significant increases in mean arterial blood pressure (122±2 and 145±4 mmHg for salt and salt-and clotrimazole-treated rats, respectively). The salt-and clotrimazole-dependent hypertension is accompanied by reductions in the urinary excretion of epoxygenase metabolites and by a selective inhibition of the renal microsomal epoxygenase reaction. The prohypertensive effects of clotrimazole are readily reversed when either the salt or clotrimazole treatment is discontinued. The indication that a salt-inducible renal epoxygenase protects against hypertension, are supported by studies with the Dahl rat model of genetic salt-sensitive hypertension. Dahl resistant animals responded to excess dietary salt by inducing the activity of their kidney microsomal epoxygenase(s) (0.102+0.01 and 0.240+0.04 nmol of products formed/min per mg of microsomal protein for control and salt-treated rats, respectively). Despite severe hypertension during excess dietary salt intake (200+20 mmHg), Dahl salt-sensitive rats demonstrated no increase in renal epoxygenase activity.
Introduction
Arachidonic acid serves as the precursor for a variety of potent mediators of cell and organ function, including prostanoids and leukotrienes (1, 2, and references therein). More recently, a considerable body of evidence has demonstrated that microsomal cytochrome P450 also participates in the bioactivation of arachidonic acid (3) (4) (5) , and references therein). The rat kidney microsomal cytochrome P450 arachidonic acid epoxygenase catalyzes the NADPH-dependent, enantiospecific, formation of 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids (EET)1 (5) . To date, epoxygenase activity has been demonstrated in numerous rodent and human tissues, including liver, kidney, brain, pituitary, adrenal, ovaries, lung, and endothelium (3) (4) (5) (6) . Interest in defining the functional significance of the cytochrome P450 epoxygenase has been stimulated by, among other things, the demonstration of a role for this enzyme in the in vivo metabolism of arachidonic acid and by the potent in vitro and in vivo biological activities of its metabolites (3) (4) (5) . Among the biological activities attributed to the EET or to their hydration products, the corresponding vic-dihydroxyeicosatrienoic acids (DHET), those of significance to the renal regulation of salt and water balance include (a) inhibition of Na+ reabsorption and K+ secretion in the rabbit cortical collecting tubule (7), (b) inhibition of Na+ transport by the proximal tubule (8) , (c) inhibition of vasopressin-stimulated water reabsorption in the collecting tubule (9, 10) , (d) enantioselective intrarenal vasoconstriction (11) and, (e) modulation of renal Na+, K+ ATPases (12) .
In normal Sprague-Dawley rats excess dietary salt results in marked increases in the urinary excretion of epoxygenase metabolites (13) . Metabolic and immunological evidence demonstrated that a high salt diet induces a cytochrome P450 isoform which is either absent or present at very low concentrations in the kidneys of untreated animals (13) . Increased salt intake results in increased renal salt excretion. This efficient adaptive process prevents progressive salt retention, volume expansion and, one of its detrimental sequelae, hypertension. The association between an increased salt intake and the marked increases in renal epoxygenase activity and urinary excretion of EET and DHET, in conjunction with the known functional effects of the EET as inhibitors of proximal and distal nephron Na+ absorption (4, 7, 8) , suggested that the salt-inducible cytochrome P450 arachidonic acid epoxygenase may be one of the functionally significant components of the kidney's adaptive response to an increased salt intake.
Earlier studies with the spontaneously hypertensive rat model (SHR/WKY) indicated that the renal cytochrome P450 arachidonic acid monooxygenase system may be of importance in the pathophysiology of hypertension (4) . Thus, in this rat model, the developmental phase of hypertension was temporally linked to attendant increases in the activities of the kidney microsomal w/w-l oxygenase (4). More recently, the gene coding for cytochrome P450 4A2 was shown to be preferentially expressed in SHR animals (14) . The demonstration that (a) the cytochrome P450 arachidonic acid epoxygenase is a member of the endogenous arachidonic acid metabolic cascade in human and rodent kidneys, (b) in humans, pregnancy induced hypertension results in substantial increases in the urinary excretion of DHTE (15) , and (c) the renal epoxygenase is regulated by excess dietary salt (13) further supports the proposal that this enzyme system may be a participant in the mechanisms by which the kidneys control body salt and fluid composition. Analytical procedures. For negative ion chemical ionization/gas chromatography/mass spectral analysis and quantification, urine samples were collected, overnight (8-12-h periods), over 5-10 mg of triphenylphosphine (13, 17) . Each individual sample was mixed, filtered, and 10-20-ml aliquots were then withdrawn for analysis. After acidification and extraction with 2 vol of CHCl3/CH30H (2:1), the urinary concentration of EET and DHET was determined by a combination of the isotope dilution/gas chromatography/mass spectroscopic techniques previously described (13, 17) . Urine creatinine was measured using a Sigma Diagnostics Creatinine Kit (Sigma Chemical Co.) and the manufacturer's instructions. Sodium concentrations were determined by flame photometry.
Results
To ascertain the functional significance of the induction of the kidney cytochrome P450 arachidonic acid epoxygenase in response to excess dietary salt, groups of age-matched rats were treated with salt and clotrimazole, an arachidonic acid epoxygenase inhibitor (18) , as indicated in Methods. From each group of animals 8-12 h urine samples were collected and, after light anesthesia, their MABP measured. As shown in Fig.  1 , compared with control animals (group A), clotrimazole treatment (group B) resulted only in minor changes in urine volume or in the urinary excretion of epoxygenase metabolites. In contrast, increased dietary salt (group C) induced a 5-6-fold increase in urine volume and, as previously reported (13) Figure 2 . Changes in the urinary excretion of sodium and in mean arterial blood pressure of rats administered either clotrimazole, excess salt, or a combination of both. For these experiments, measurements were performed using the same groups of animals used in Fig. 1 . Sodium concentrations were determined by flame photometry. MABP was measured as described in Methods. Animals were then killed, under anesthesia, by heart puncture, their kidneys removed free of connective tissue and used for the isolation of microsomal fractions as described in Methods.
concomitant 6-7-fold increase in the urinary excretion of epoxygenase metabolites ( Fig. 1) . Within 48 h of clotrimazole treatment, the salt-loaded animals (group D) showed significant decreases in urine volume (74±2 and 52±6 ml/d for salt and salt plus clotrimazole treated, respectively; n = 5 ) ( Fig. 1 ) and in the urinary excretion of EET and DHET (6.2±+1.4 and 3.3+±0.6 ng/mg of creatinine for salt and salt plus clotrimazole treated, respectively; n = 5) (Fig. 1) . The effects of inhibition of the cytochrome P450 arachidonate epoxygenase on Na+ excretion and arterial blood pressure are shown in Fig. 2 . After two daily injections of clotrimazole, animals fed 0.4% sodium diets showed no change in their urinary Na+ excretion (0.42±0.03 and 0.33±0.03 equivalents/ 24 h for control (A) and clotrimazole treated animals (B), respectively, n = 6). In these animals, mean arterial blood pressure (MABP) fell slightly (125±3 and 115±3 mmHg for control (A) and clotrimazole treated (B), respectively; n = 5) (Fig. 2) . On the other hand, the animals fed a high salt diet (C) responded by increasing their urinary Na + excretion nearly 14-fold (5.89+0.16 equivalents/24 h n = 9). Dietary salt loading did not result in a significant elevation of MABP [122+2 mmHg in salt loaded (C) vs 125+±3 mmHg in controls (A), n = 5] (Fig. 2) . However, in animals fed a high salt diet and treated with the cytochrome P450 inhibitor (group D), urinary Na+ excretion was reduced almost by half (3.50±0.57 equivalents/24 h, n = 6) while the MABP of these animals increased to 145±4 mmHg (n = 9) (Fig. 2) . Importantly, animals became hypertensive only after the combined effects of salt loading and clotrimazole treatment (Fig. 2) . When either the clotrimazole treatment was stopped or the high salt diet was replaced by regular, 0.4% sodium chow, the blood pressure of the hypertensive animals (group D) returned to normal (within 2 of the endogenous kidney epoxygenase, kidney microsomal fractions, isolated from the kidneys of hypertensive, high saltand clotrimazole-treated animals (group D), as well as from the high salt, normotensive (group C), were incubated with [1-'4C]arachidonic acid (100 suM) and NADPH (1 mM) (16) . After 10-20 min at 30°C, the reaction products were extracted and resolved by reversed phase HPLC ( 16) . As is evident from the chromatograms in Fig. 3 , animal treatment with clotrimazole resulted in a marked and selective inhibition of the epoxygenase reaction (-15% of control rates, n = 4) with little or no effect on the microsomal w/w-1 arachidonate oxygenase (2 90% of control rates, n = 4). This confirmed earlier studies with rat liver microsomes where clotrimazole was shown to be epoxygenase specific (18) . Using an experimental protocol identical to the one described above, we showed that administration of the cyclooxygenase inhibitor, indomethacin (80 mg/kg body wt, i.p.), had no significant effects on the systemic blood pressure of saltloaded animals. Also, and as previously shown ( 19) , NG-monomethyl-L-arginine, an NO-synthase inhibitor (20) , administered as a 0.2% (wt/vol) solution in the drinking water for 10 d caused a marked increase in the animals MABP (115±15 and 180±20 mmHg for control and NG-monomethyl-L-argininetreated animals, respectively). In these animals, the arginine analogue did not alter the activity of the kidney microsomal arachidonic acid epoxygenase or w/w-I oxygenase, nor did it induce significant changes in the urine or plasma concentrations of epoxygenase metabolites. Importantly, the prohypertensive effect of NG-monomethyl-L-arginine was independent of salt loading and/or clotrimazole treatment.
These results strongly support the hypothesis that the kidney isolated from animals maintained either in the low salt (equivalent to 1% NaCl wt/wt) (A) or high salt diets (8% NaCl wt/wt) (B) were analyzed using the incubation conditions and the analytical methodology described in Fig. 3 . The radiochromatograms shown were generated by incubating 0.75 mg of microsomal protein at 30'C for 20 min. Shown in the chromatograms are the approximate retention times for a mixture of 19-and 20-hydroxyeicosatetraenoic acids (w/w-l) and of 14,15-, 11,12-, 8,9-, and 5,6-epoxyeicosatrienoic acids (EET). microsomal arachidonic acid epoxygenase plays a functionally significant role in the control of Na+ homeostasis and systemic blood pressure. To further explore the potential links between dietary salt, blood pressure, and the renal cytochrome P450 epoxygenase we used the Dahl rat model of genetic salt-dependent hypertension. In these animals, genetically controlled alterations in renal Na+ metabolism lead to the development of systemic hypertension after salt loading (21 and references therein, and 22). For these studies, groups of DS and DR rats (280-300 g body wt) were fed either a standard laboratory rat chow (0.4% sodium) or a modified high salt diet (8% NaCl) for 2-3 wk. At the end of this time period, systemic blood pressures were measured, the animals killed, their kidneys removed, microsomal fractions isolated and incubated with [1- 14C ] arachidonic acid in the presence of NADPH. After extraction, the reaction products were resolved by reversed phase HPLC (16) . No significant differences in the rates of total arachidonic acid metabolism were observed by incubating microsomal fractions obtained from either the DR (MABP = 120± 10 mmHg) or DS (MABP = 130±15 mmHg) animals fed the low salt diet (Fig. 4 A) (Table I) . As with SpragueDawley animals (13), the DR rats responded to the high salt diet with an overall increase in their renal arachidonic acid oxygenase activity (149% of the rates obtained with control, non-salt-treated rats) ( Table I ). These salt induced changes could be almost completely accounted for by a salt-dependent 235% increase in the kidney epoxygenase activity of DR rats (Table I) . Importantly, during the course of salt loading, the DR animals remained essentially normotensive (MABP = 130_10 mmHg). In contrast, under the same experimental conditions, the DS animals were unable to induce their renal microsomal epoxygenase activity in response to salt loading (Table I) (Fig.  4 B) . (Fig. 4, A and B) .
To substantiate the in vivo significance of these observations, groups of DR and DS animals were allowed to drink either water or a 2% solution of NaCl for 7-10 d and, after extraction and purification, the concentration of epoxygenase metabolites in their urine was measured by GC/MS techniques (17) . To improve reproducibility a 2% NaCl solution, instead of the solid diet containing 8% NaCl, was used as the source of high dietary salt (13) . As with Sprague-Dawley animals, excess dietary salt resulted in an increased urinary excretion of epoxygenase metabolites (expressed as ng of DHET/mg of creatinine) by both DR and DS rats (Fig. 5) . However, while for DS animals the excretion of individual epoxygenase metabolites was approximately doubled, with the DR animals salt induced 9-, 8-, 7-and 4-fold increases in the urinary excretion of 8,9-, 11,12-, 14,15-, and 5,6-EET + DHET, respectively (Fig. 5) . Importantly, when compared to nontreated controls, excess dietary salt resulted in significant decreases in the urine concentration of epoxygenase metabolites (expressed as ng of product/ ml of urine) only in the DS animals (Fig. 5) . On the other hand, the urine of salt-treated DR rats showed significant increases in the levels of epoxygenase products (Fig. 5) . It Figure 5 . Changes in the urinary concentrations of epoxygenase metabolites after the administration of high salt to salt-sensitive (DS) and saltresistant (DR) Dahl rats. Groups of male DR and DS rats (280-300 g body wt) were allowed to drink freely either water or a 2% solution of NaCl for 7-8 d. Urine samples were collected over triphenylphosphine for 8-12 h and, after extraction and purification, their EET and DHET contents determined by gas chromatography/mass spectrometry techniques as described (17) . Salt-induced changes in the urine concentration of epoxygenase metabolites in ng/ml of urine or ng/mg of creatinine are expressed as percent of values obtained with control, non-salttreated animals. Values shown are the averages±SE calculated from four different experiments.
Discussion
The initial reports of oxidative metabolism of arachidonic acid by microsomal cytochrome P450 suggested a role for the enzyme system in the bioactivation of this important fatty acid (24) (25) (26) . The significance of these reactions was subsequently highlighted by the demonstration of stereospecific, in vivo, EET formation by various rat, rabbit, and human organs, and by the demonstration of microsomal cytochrome P450 as a member of the arachidonate metabolic cascade (5). Work from several laboratories, including ours, has documented the potent effects of several of the cytochrome P450 arachidonate metabolites in renal Na+, K + and H20 fluxes (4, 5 ) . Additionally, a prohypertensive role for products of the cytochrome P450 arachidonic acid w/w-1 oxygenase was proposed, early on, by McGiff and collaborators (4) . In rats, excess dietary salt results in marked and selective increases in the activity of the renal cytochrome P450 epoxygenase (13) . This metabolic response, as well as the documented effects of epoxygenase products on renal H20 and Na + transport and, in particular, the early demonstration of an inhibition of Na+ reabsorption in the isolated cortical collecting tubule by EETs (4, 7) lead us to propose that the epoxygenase may be part of the adaptive response of the kidney to excess Na+ intake. Clotrimazole and ketoconazole, powerful inhibitors of microsomal cytochrome P450 (18) , have been used in the past to characterize the functional significance of the hemoprotein in several isolated cell or whole organ preparations (4, 27, 28) . We have shown, using rat liver microsomal fractions, that clotrimazole selectively inhibits the arachidonic acid epoxygenase and that it is a substantially less effective inhibitor of the arachidonic acid w/w-1 oxygenase reaction (18) . The demonstration that Sprague-Dawley rats can be made hypertensive by the combined effects of salt loading and inhibition of their renal epoxygenase indicated a role for this enzyme system in renal Urine samples were collected from male DS and DR animals exactly as in Fig. 5 . After extraction and purification the concentration of each individual EET and DHET was determined by gas chromatography/ mass spectral technique as described (17) . To calculate the percent distribution of the different epoxygenase products, the concentration of the each individual EET was added to that of the corresponding DHET positional isomer. Values shown are averages calculated from four different experiments with SE of the mean 5 15% of the averages.
Na+ metabolism. However, as with most inhibitor studies, this interpretation must take into consideration other possible actions of clotrimazole, not directly associated with inhibition of the renal epoxygenase. Thus, for example, clotrimazole has been shown to inhibit steroid hydroxylases (29) . Nevertheless, two well-known factors make it unlikely that the functional effects described are caused by inhibitor-dependent modifications in steroid production (a) under conditions of excess dietary salt, as those used here, mineralocorticoid biosynthesis is suppressed, and (b) adrenal steroid effects on blood pressure usually develop weeks after experimental manipulation of mineralocorticoid levels. Additionally, the demonstration that indomethacin, a potent inhibitor of prostanoid biosynthesis, had no significant effects on the MABP of salt-loaded animals provided strong evidence that, under our experimental conditions, the effects of clotrimazole were cyclooxygenase independent. Finally, initial spectral studies suggested that nitric oxide (NO) synthase may be a cytochrome P450 type protein (30, 31) . However, subsequent amino acid sequence comparisons showed the lack of significant structural homologies between these proteins, including the absence in the NO synthase proteins of conserved cytochrome P450 domains essential for catalytic activity (32) . More recently, it has been shown that clotrimazole does not inhibit the metabolism of L-arginine to L-citrulline by the NO synthase of endothelial cells (33) and that, in the isolated perfused rat kidney, the NO-dependent component of the vasodilator effect of bradykinin is not affected by clotrimazole (34) . Previous studies indicated that (a) the renal epoxygenase (s) belong to the cytochrome P450 2C gene subfamily (6, 13, 35, 36) , (b) cytochrome P450 2C23 is the predominant, constitutive, epoxygenase isoform in the rat kidney (35) and, (c) excess dietary salt induces a renal cytochrome P450 2C isoform that appears to be different than cytochrome P450 2C23 (13, 35 (21) . In this rat model of salt-sensitive hypertension, genomic differences are responsible for functional differences in renal salt handling and the development of systemic hypertension in the DS genotype (21, 22) . While in these animals, as in humans, hypertension is most likely a polygenic trait, transplantation studies clearly demonstrated that the kidney genotype played a pivotal role in the blood pressure response to increased dietary salt (22) . Although the molecular basis underlining the saltsensitive hypertension phenotype are yet to be fully understood, in the past, several biochemical alterations have been documented in the DS rat, including alterations in the regulation of renal Na+, K+ ATPases by dopamine (38, 39) , the biosynthesis of mineralocorticoids (40, 41 ) and, the structure of the genes coding for renin (42) and Na+, K+ ATPases (43, 44) . The results reported here demonstrate that, as with normal SpragueDawley animals (13) , DR rats responded to an increase salt intake by inducing the activity of their kidney cytochrome P450 AA epoxygenase and thus, upregulating the concentration of epoxygenase metabolites in the urine. On the other hand, saltloaded DS rats appeared unable to induce the activities of the renal epoxygenase and, as a consequence, the urinary concentration of their epoxygenase metabolites decreased. Hence, concomitant with increases in dietary salt intake, only the DR animals appeared capable of upregulating their epoxygenase activity and thus, prevent a fall in the urinary concentration of epoxygenase metabolites.
Our studies in two strains of rats, one in which hypertension can be induced during salt loading by inhibiting the arachidonate epoxygenase and, the other, the Dahl salt-sensitive model, in which a genetic predisposition to salt-dependent hypertension has been associated with a functional defect in the response of the renal arachidonate epoxygenase to excess dietary salt ( 13, 35) , indicate an antihypertensive role for this enzyme system. Hence, it appears that an increased epoxygenase activity may prevent systemic hypertension in response to excess dietary salt. Indeed, one of the epoxygenase metabolites, 5,6-EET, is a powerful inhibitor of Na+ absorption in the distal nephron (7) . However, the details of the mechanisms by which the epoxygenase metabolites may regulate renal Na+ and/or H20 homeostasis, as well as the molecular mechanism by which dietary salt regulates the biosynthesis of the arachidonate epoxygenase(s), remain to be established.
The importance of microsomal cytochrome P450 as the catalyst for the oxidative transformation of several xenobiotics is well established (45 and references therein). In addition to its recognized toxicological and pharmacological relevance, the last few years have witnessed a renewed interest in exploring and defining additional functional roles for this enzyme system (3-5, 46 and references therein). The present experimental evidence, as well as that of others (3) (4) (5) , indicates that this enzyme system may be a significant component of the physiological mechanisms that control body fluid volume and composition. Indeed, it appears that either pharmacological inhibition or an inherited disorder of renal epoxygenase activity (or its regulation) predisposes to salt-sensitive hypertension in rodents. These results, in conjunction with previous studies from several laboratories (3) (4) (5) provide decisive evidence that microsomal cytochrome P450, as a participant of the arachidonic acid metabolic cascade, plays significant functional roles in controlling tissue and body homeostasis. Current efforts are directed towards the identification of the kidney epoxygenase isoform(s) responsive to excess dietary salt, as well as the molecular characterization of phenotypic differences in salt-dependent epoxygenase activities and/or regulation between the Dahl DR and DS genotypes. Since salt sensitivity is an important feature of hypertension in a large subpopulation of humans with essential hypertension, there are important clinical reasons for studying the molecular, catalytic, and genetic properties of the corresponding human homologues of the rat cytochrome P450 2C subfamily isoforms. We are confident that the results reported here will serve to further stimulate research in this clinically important area.
